A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
Clinical trial NCT03316898 · WITHDRAWN
Trial details
- NCT number
- NCT03316898
- Sponsor
- Allergan
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-30
- Primary completion
- 2018-11-04
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.